Assessing chaperone for Zn, Cu-superoxide dismutase as an indicator of copper deficiency in malnourished children

Journal of Trace Elements in Medicine and Biology

Volumn 28, Issue 1, 2014, Pages 23-27

  Arredondo, Miguel ^a,c   Weisstaub, Gerardo ^a,c   Medina, Marcos ^b,c   Suazo, Miriam ^a,c   Guzmán, Miguel ^b   Araya, Magdalena ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSIDAD MAYOR DE SAN SIMÓN   (Bolivia)

^c NONE   (Chile)

Author keywords

CCS; Copper deficiency; Malnutrition; SOD

Indexed keywords

C REACTIVE PROTEIN; CERULOPLASMIN; CHAPERONE; COPPER ZINC SUPEROXIDE DISMUTASE; MELATONIN 2 RECEPTOR; MESSENGER RNA;

ANTHROPOMETRIC PARAMETERS; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; COPPER BLOOD LEVEL; COPPER DEFICIENCY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IRON BLOOD LEVEL; MALE; MALNUTRITION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; ZINC BLOOD LEVEL;

CCS; COPPER DEFICIENCY; MALNUTRITION; SOD;

CHILD NUTRITION DISORDERS; CHILD, PRESCHOOL; COPPER; FEMALE; HUMANS; INFANT; MALE; SUPEROXIDE DISMUTASE;

EID: 84890861285     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2013.10.004     Document Type: Article

References (35)

1. Danks D.M. Disorders of copper transport. The metabolic and molecular bases of inherited disease 1995, 2211-2235. McGraw-Hill, New York. C.L. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
2. Vulpe C., Levinson B., Whitney S., Packman S., Gitschier J. Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase. Nat Genet 1993, 3:7-13.
3. Danks D.M. Copper deficiency in humans. Ann Rev Nutr 1988, 8:235-257.
4. Griffith D.P., Liff D.A., Ziegler T.R., Esper G.J., Winton E.F. Acquired copper deficiency: a potentially serious and preventable complication following gastric bypass surgery. Obesity 2009, 17:827-831.
5. Henri-Bhargava A., Melmed C., Glikstein R., Schipper H.M. Neurologic impairment due to vitamin E and copper deficiencies in celiac disease. Neurology 2008, 71:860-861.
6. Halfdanarson T.R., Kumar N., Hogan W.J., Murray J.A. Copper deficiency in celiac disease. J Clin Gastroenterol 2009, 2:162-164.
7. Cordano A., Baertl J.M., Graham G. Copper deficiency in infancy. Pediatrics 1964, 34:324-336.
8. Prasad A.S., Brewer G.J., Schoomaker E.B., Rabbani P. Hypocupremia induced by zinc therapy. JAMA 1978, 240:2166-2168.
9. Dauncey M.J., Shaw J.C.L., Urman J. The absorption and retention of magnesium, zinc, and copper by low birth weight infants fed pasteurized human breast milk. Pediatr Res 1977, 11:991-997.
10. Shaw J.C.L. Copper deficiency in term and preterm infants. Nutritional anemias, Nestlé nutrition workshop series vol. 30 1992, 105-119. Raven New York/Vevey:Press/Nestec. S.J. Fomon, S. Zlotkin (Eds.).
11. Kawada E., Moridaira K., Itoh K., Hoshino A., Tamura J., Morita T. In long-term bedridden elderly patients with dietary copper deficiency, biochemical markers of bone resorption are increased with copper supplementation during 12 weeks. Ann Nutr Metab 2006, 50:420-424.
12. Weisstaub G., Medina M., Pizarro F., Araya M. Copper, iron and zinc status in moderately and severely malnourished children recovered following WHO protocols. Biol Trace Elem Res 2008, 124:1-11.
13. Olivares M., Lera L., Albala C., Pizarro F., Araya M. Prevalence of zinc and copper deficiencies in older subjects living in Metropolitan Santiago. Rev Med Chile 2011, 139:283-289.
14. Harvey L.J., Ashton K., Hooper L., Casgrain A., Fairweather-Tait S.J. Methods of assessment of copper status in humans: a systematic review. Am J Clin Nutr 2009, 89:2009S-2024S.
15. Danzeisen R., Araya M., Harrison B., et al. How reliable and robust are current biomarkers for copper status?. Br J Nutr 2007, 98:676-683.
16. Culotta V.C., Klomp L.W.J., Strain J., Casareno R.L.B., Krems B., Gitlin J.D. The copper chaperone for superoxide dismutase. J Biol Chemist 1997, 272:23469-23472.
17. Casareno R.L.B., Waggoner D., Gitlin J.D. The copper chaperone CCS directly interacts with copper/zinc superoxide dismutase. J Biol Chem 1998, 273:23625-23628.
18. Rothstein J.D., Dykes-Hoberg M., Corson L.B., Becker M., Cleveland D.W., Price D.L., et al. The copper chaperone CCS is abundant in neurons and astrocytes in human and rodent brain. J Neurochem 1999, 72:422-429.
19. Schmidt P.J., Rae T.D., Pufahl R.A., Hamma T., Strain J., O'Halloran T.V., et al. Multiple protein domains contribute to the action of the copper chaperone for superoxide dismutase. J Biol Chem 1999, 274:23719-23725.
20. Bertinato J., L'Abbe M.R. Copper modulates the degradation of copper chaperone for Cu-Zn superoxide dismutase by the 26 S Proteosome. JBC 2003, 278:35071-35078.
21. Philip C.W., Darrel W., Subramaniam J.R., Tessarollo L., Bartnikas T.B., Culotta V.C., et al. Copper chaperone for superoxide dismutase is essential to activate mammalian Cu/Zn superoxide dismutase. PNAS 2000, 97:2886-2891.
22. Iskandar M., Swist E., Trick K.D., Wang B., L'Abbé M.R., Bertinato J. Copper chaperone for Cu/Zn superoxide dismutase is a sensitive biomarker of mild copper deficiency induced by moderately high intakes of zinc. Nutr J 2005, 4:35.
23. Suazo M., Olivares F., Méndez M.A., Pulgar R., Prohaska J.R., Arredondo M., et al. CCS and SOD1 mRNA are reduced after copper supplementation in peripheral mononuclear cells of individuals with high serum ceruloplasmin concentration. J Nutr Biochem 2007, 19:269-274.
24. Araya M., Andrews M., Pizarro F., Arredondo M. Chaperones CCS, ATOX and COX IV responses to copper supplementation in healthy adults. Biometals 2012, 25:383-391.
25. WHO Management of severe malnutrition: a manual for physicians and other senior health workers 1999, WHO Publications, Geneva.
26. Ashworth A., Chopra M., McCoy D., Sanders D., Jackson D., Karaolis N., et al. WHO: guidelines for management of severe malnutrition in rural South African hospitals: effect on case fatality and the influence of operational factors. Lancet 2004, 363:1110-1115.
27. Bhan M.K., Bhandari N., Bahl R. Management of the severely malnourished child: perspective from developing countries. BMJ 2003, 326:146-151.
28. WHO child growth standards: length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development. Coordinating team: Mercedes de Onis 2006, World Health Organization, Geneva.
29. Uauy R., Castillo Duran C., Fisberg M., Fernandez N., Valenzuela A. Red cell superoxide dismutase activity as an index of human copper nutrition. J Nutr 1985, 115:1650-1655.
30. Milne D. Copper intake and assessment of copper status. Am J Clin Nutr 1998, 67:1041S-5S.
31. International Zinc Nutrition Consultative Group (IZINCG) Assessment of the risk of zinc deficiency in populations and options for its control. Food Nutr Bull 2004, 25:94-200.
32. Hotz C., Peerson J., Brown K. Suggested lower cut-offs of serum zinc concentrations for assessing zinc status: reanalysis of the second National Health and Nutrition Examination Survey data (1976-1980). Am J Clin Nutr 2003, 78:756-764.
33. INAGG Adjusting hemoglobin values in program surveys 2002, Steering Committee, Washington, DC.
34. Olivares M., Walter T., Cook J., Hertrampf E., Pizarro F. Usefulness of serum transferrin receptor and serum ferritin in diagnosis of iron deficiency in infancy. Am J Clin Nutr 2000, 72:1191-1195.
35. Harvey L.J., McArdle H.J. Biomarkers of copper status: a brief update. Br J Nutr 2008, 99(Suppl. 3):S10-S13.